AZD1208

CAT: 0804-HY-15604-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-15604-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
AZD1208 is an orally bioavailable, highly selective PIM kinases inhibitor[1].
CAS Number
[1204144-28-4]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Autophagy; Pim
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; JAK/STAT Signaling
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AZD1208.html
Purity
99.73
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NC/1=O)SC1=C/C2=C(N3C[C@H](N)CCC3)C(C4=CC=CC=C4)=CC=C2
Molecular Formula
C21H21N3O2S
Molecular Weight
379.48
Precautions
H302, H315, H319, H335
References & Citations
[1]Dakin LA, et al. Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases. Bioorg Med Chem Lett. 2012 Jul 15;22 (14) :4599-604.|[2]Kreuz S, et al. Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas. Mol Cancer. 2015 Dec 8;14:205.|[3]Harada M, et al. The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression. Oncotarget. 2015 Nov 10;6 (35) :37930-47.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
PIM2

Related Products

CatalogName
HY-U00064-01AZD2098
HY-15799-01AZD1283
HY-12733AZD5248
HY-13862-01AZD1080

Alternative Products

CatalogName
MBS384280-01AZD1208
A13203-10AZD1208 10mg
A13203-200AZD1208 200mg
MBS5804843AZD1208 hydrochloride
A13203-25AZD1208 25mg
A13203-50AZD1208 50mg
A13203-500AZD1208 500mg

Popular Products